Fiera Capital (Canada)’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Fiera Capital (Canada)’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-37,111	Closed	-$4.4M	–	628
2022 Q1	$4.4M	Sell	37,111 -1,466	-4%	-$183K	0.01%	218
2021 Q4	$5.32M	Sell	38,577 -3,077	-7%	-$391K	0.01%	199
2021 Q3	$5.79M	Sell	41,654 -500	-1%	-$62.4K	0.01%	191
2021 Q2	$4.09M	Sell	42,154 -2,999	-7%	-$243K	0.01%	214
2021 Q1	$3.09M	Buy	45,153 +1,550	+4%	+$125K	0.01%	237
2020 Q4	$3.74M	Sell	43,603 -679	-2%	-$57.5K	0.01%	271
2020 Q3	$2.88M	Sell	44,282 -1,254	-3%	-$82.2K	0.01%	281
2020 Q2	$3.33M	Sell	45,536 -1,708	-4%	-$90.9K	0.01%	268
2020 Q1	$1.61M	Sell	47,244 -1,758	-4%	-$80.4K	0.01%	351
2019 Q4	$2.67M	Sell	49,002 -1,105	-2%	-$54.7K	0.01%	321
2019 Q3	$2.09M	Buy	+50,107	New	+$2.12M	0.01%	344

Other funds holding BHVN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fiera Capital (Canada)'s BHVN Position: Q2 2022 in Review

Fiera Capital (Canada) sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q2 2022, closing a stake of 37,111 shares — an estimated $4.4M sold.

Fiera Capital (Canada) first reported a position in BHVN in Q3 2019 and held it in 11 quarters. The position peaked at $5.79M in Q3 2021. 329 funds tracked by Wall St. Rank hold BHVN as of Q2 2022.

Fiera Capital (Canada) reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q2 2022 after selling out during the quarter.
Fiera Capital (Canada) sold 37,111 Biohaven Pharmaceutical Holding Company Ltd. shares in Q2 2022, an estimated $4.4M.
Fiera Capital (Canada) first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q3 2019 and held it in 11 quarters.
Fiera Capital (Canada)'s Biohaven Pharmaceutical Holding Company Ltd. position peaked at $5.79M in Q3 2021.
329 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q2 2022.

Based on Fiera Capital (Canada)'s 13F filing for Q2 2022, filed 10 Aug 2022.